Quantitative analysis of angiogenesis using confocal laser scanning microscopy.

Area of Science:

• Oncology
• Biomedical Imaging
• Vascular Biology

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
• Microvessel density (MVD) is a standard metric for quantifying tumor angiogenesis.
• Traditional light microscopy methods for MVD assessment may lack precision and detailed architectural insights.

Purpose of the Study:

• To compare the efficacy of confocal laser scanning microscopy (CLSM) against light microscopy for the qualitative and quantitative analysis of angiogenesis.
• To evaluate the accuracy of CLSM in measuring microvessel density (MVD) in tumor models.
• To assess the utility of CLSM in analyzing the antiangiogenic effects of cancer therapies.

Main Methods:

• CD31 immunohistochemical staining was performed on lung tumor xenografts and skeletal muscle tissues.
• Manual MVD determination using light microscopy.
• Automated MVD measurement and 3D microvessel reconstruction using computer-assisted CLSM.
• Application of the CLSM method to evaluate the antiangiogenic effects of paclitaxel.

Main Results:

• Light microscopy yielded a relative MVD of 0.8 for tumor versus skeletal muscle.
• Computer-assisted CLSM determined a significantly higher relative microvessel level of 3.4.
• CLSM provided superior delineation of microvessel architecture compared to light microscopy.
• The CLSM method successfully analyzed the antiangiogenic impact of paclitaxel.

Conclusions:

• CLSM is a highly effective method for both quantitative and qualitative assessment of microvasculature in normal and tumor tissues.
• CLSM offers more accurate MVD quantification and detailed architectural analysis than light microscopy.
• This advanced imaging technique holds significant potential for cancer research and drug development, particularly in evaluating antiangiogenic therapies.